查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654352

全球人体肝臟模型市场：市场规模、份额、趋势分析（按产品、应用、最终用途和地区）、细分市场预测（2025-2030 年）

Human Liver Model Market Size, Share & Trends Analysis Report By Product (2D Models, 3D Models), By Application (ADME Studies, Toxicology Testing), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

人体肝臟模型市场规模与趋势：

预计 2024 年全球人体肝臟模型市场规模将达到 13.4 亿美元，2025 年至 2030 年的复合年增长率为 14.04%。

该行业成长的推动因素包括肝病发病率不断上升、器官列印技术的进步以及治疗肝癌药物的需求不断增加等因素。

据美国卫生资源与服务管理局称，到 2023 年，美国将有 106,800 人等待器官移植。医疗保健格局正在发生变化，3D 列印技术的进步有望透过解决器官短缺问题和改善全球患者照护来改变医疗保健。

全球肝病的发生率不断上升，推动了对人类肝臟模型等先进研究工具的需求。由于不健康饮食、久坐的生活方式、饮酒和病毒感染等因素，非酒精性脂肪肝（NAFLD）、酒精性肝病、病毒性肝炎和肝癌等慢性肝病变得越来越常见。例如，NAFLD是西方国家最常见的慢性肝病，影响着全球约25％的人口。肝病发生率的急剧上升迫切需要更准确、更有效的人体肝臟模型来辅助研究和药物开发。

器官3D列印技术最近取得了重大进展，特别是在人体肝臟模型的开发方面。这些进步为研究目的提供了更准确和个人化的模型，从而彻底改变了再生医学和药物测试。例如，2023年2月，加州大学圣地牙哥分校的研究人员在解决3D组织生物列印的挑战方面取得了重大进展，实现了高细胞密度、活力和精确的列印解析度。

目录

第一章 分析方法及范围

第 2 章执行摘要

3. 人体肝臟模型市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 人体肝臟模型市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL 分析
    • COVID-19影响分析

第 4 章 人体肝臟模型市场：按产品分類的估计和趋势分析

  • 特定于产品的仪表板
  • 人体肝臟模型市场：依产品差异分析
  • 人体肝臟模型市场：按产品分類的市场规模预测和趋势分析（2018-2030 年）
  • 2D 模型
    • 细胞株
    • 初代细胞
  • 3D 模型
    • 晶片上的槓桿
    • 类器官
    • 球形体
    • 其他的

第 5 章 人体肝臟模型市场：按应用分類的估计和趋势分析

  • 用于特定目的的仪表板
  • 人体肝臟模型市场：按应用进行的变化分析
  • 人体肝臟模型市场：按应用分類的市场规模预测和趋势分析（2018-2030）
  • ADME 研究
  • 毒性测试
  • 疾病模型
  • 其他的

第六章 人体肝臟模型市场：依最终用途的估计与趋势分析

  • 按最终用途分類的仪表板
  • 人体肝臟模型市场：依最终用途的变化分析
  • 人体肝臟模型市场：按最终用途分類的市场规模预测和趋势分析（2018-2030 年）
  • 学术研究所
  • 製药和生物技术公司
  • CRO

第七章人体肝臟模型市场：区域估计与趋势分析

  • 人体肝臟模型市场：按产品、应用和最终用途分類的区域估计和趋势分析
  • 市场仪表板：按地区
  • 各地区市场占有率（2024 年及 2030 年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 公司/竞争对手分类
  • 战略地图
  • 企业市场分析（2024）
  • 公司简介
    • ATCC
    • Merck KGaA
    • AcceGen
    • ZenBio, Inc.
    • Organovo Holdings Inc.
    • BioIVT
    • InSphero
    • Emulate, Inc.
    • Mimetas
    • CN Bio Innovations Ltd
Product Code: GVR-4-68040-355-1

Human Liver Model Market Size & Trends:

The global human liver model market size was valued at USD 1.34 billion in 2024 and is projected to grow at a CAGR of 14.04% from 2025 to 2030. The industry is driven by the increasing prevalence of liver diseases, advancements in organ printing technologies, and increased demand for therapeutic drugs for liver cancer, which is expected to propel its growth.

According to the Health Resources & Services Administration, in 2023, in the U.S., 106,800 individuals are waiting for organ transplants. The healthcare landscape is evolving, and advancements in 3D printing technology are set to transform healthcare by addressing organ shortages and improving patient care globally.

The prevalence of liver diseases is on the rise globally, leading to a growing demand for advanced research tools, including human liver models. Chronic liver conditions such as non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, viral hepatitis, and liver cancer are becoming increasingly common due to factors such as unhealthy diets, sedentary lifestyles, alcohol consumption, and viral infections. For instance, NAFLD emerged as the most prevalent chronic liver disorder in Western countries, affecting approximately 25% of the global population. This significant rise in the prevalence of liver diseases has driven the urgent need for more accurate and efficient human liver models to support research and drug development efforts.

Organ 3D printing technologies have advanced significantly recently, particularly in developing human liver models. These advancements have revolutionized regenerative medicine and drug testing by providing more accurate and personalized models for research purposes. For instance, in February 2023, researchers at the University of California San Diego made significant progress in addressing challenging issues in bio-printing 3D-engineered tissues, achieving high cell density, viability, and precise fabrication resolution.

Global Human Liver Model Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global human liver model market report on the basis of product, application, end-use, and region.

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • 2D Models
    • Cell lines
    • Primary Cells
  • 3D Models
    • Liver on Chip
    • Organoids
    • Spheroids
    • Others
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • ADME Studies
  • Toxicology Testing
  • Disease Modelling
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End-use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Human Liver Model Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of liver diseases
      • 3.2.1.2. Advancements in organ printing technologies
      • 3.2.1.3. Increased demand for therapeutic drugs for liver cancer
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High costs and complexity associated with maintaining human liver models
  • 3.3. Human Liver Model Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Human Liver Model Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Human Liver Model Market Product Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Global Human Liver Model Market Size and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. 2D Models
    • 4.4.1. 2D models market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Cell Lines
      • 4.4.2.1. Cell Lines market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Primary Cells
      • 4.4.3.1. Primary Cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. 3D Models
    • 4.5.1. 3D models market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Liver on Chip
      • 4.5.2.1. Liver on Chip market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Organoids
      • 4.5.3.1. Organoids market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Spheroids
      • 4.5.4.1. Spheroids market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Human Liver Model Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Human Liver Model Market Application Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Global Human Liver Model Market Size and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. ADME Studies
    • 5.4.1. ADME Studies market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Toxicology Testing
    • 5.5.1. Toxicology Testing market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Disease Modelling
    • 5.6.1. Disease Modelling market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Human Liver Model Market: End-use Estimates & Trend Analysis

  • 6.1. End-use Segment Dashboard
  • 6.2. Global Human Liver Model Market End-use Movement Analysis, 2024 & 2030 (USD Million)
  • 6.3. Global Human Liver Model Market Size and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 6.4. Academic & Research Institutes
    • 6.4.1. Academic & Research Institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Pharmaceutical & Bioproduct Companies
    • 6.5.1. Pharmaceutical & Bioproduct Companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Contract Research Organizations
    • 6.6.1. Contract Research Organizations market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Human Liver Model Market: Regional Estimates & Trend Analysis

  • 7.1. Human Liver Model Market: Regional Estimates & Trend Analysis by Product, Application, and End-use
  • 7.2. Regional Market Dashboard
  • 7.3. Regional Market Share Analysis, 2024 & 2030
  • 7.4. North America
    • 7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Competitive scenario
      • 7.5.9.3. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. ATCC
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. AcceGen
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. ZenBio, Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Organovo Holdings Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. BioIVT
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. InSphero
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Emulate, Inc.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Mimetas
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. CN Bio Innovations Ltd
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global human liver models market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 North America human liver models market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 U.S. human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Canada human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Mexico human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Europe human liver models market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Germany human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 24 Germany human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 UK human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 27 UK human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 France human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 30 France human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 31 France human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Italy human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Spain human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Denmark human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 39 Denmark human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Sweden human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 42 Sweden human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Norway human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 45 Norway human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific human liver models market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 China human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 52 China human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 53 China human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Japan human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 55 Japan human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 India human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 58 India human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 59 India human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 South Korea human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 61 South Korea human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Australia human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 64 Australia human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Thailand human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 67 Thailand human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Latin America human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 70 Latin America human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 71 Latin America human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Brazil human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 73 Brazil human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 74 Brazil human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Argentina human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 76 Argentina human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 77 Argentina human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 MEA human liver models market, by region, 2018 - 2030 (USD Million)
  • Table 79 MEA human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 80 MEA human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 81 MEA human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 South Africa human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 83 South Africa human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 84 South Africa human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 UAE human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 89 UAE human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 90 UAE human liver models market, by end-use, 2018 - 2030 (USD Million)
  • Table 91 Kuwait human liver models market, by product, 2018 - 2030 (USD Million)
  • Table 92 Kuwait human liver models market, by application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait human liver models market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook
  • Fig. 10 Human liver models market driver impact
  • Fig. 11 Human liver models market restraint impact
  • Fig. 12 Human liver models market: Product movement analysis
  • Fig. 13 Human liver models market: Product outlook and key takeaways
  • Fig. 14 2D models market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Cell lines market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Primary cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 3D models market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Liver on chip market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Organoids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Spheroids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Human liver models market: Application movement analysis
  • Fig. 23 Human liver models market: Application outlook and key takeaways
  • Fig. 24 ADME studies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Toxicology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Disease modelling market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Human liver models market: End-use movement analysis
  • Fig. 29 Human liver models market: End-use outlook and key takeaways
  • Fig. 30 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Pharmaceutical & bioproduct companies market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 32 Contract research organizations market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Global human liver models market: Regional movement analysis
  • Fig. 34 Global human liver models market: Regional outlook and key takeaways
  • Fig. 35 Global human liver models market share and leading players
  • Fig. 36 North America
  • Fig. 37 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. key country dynamics
  • Fig. 39 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada key country dynamics
  • Fig. 41 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Mexico key country dynamics
  • Fig. 43 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Europe
  • Fig. 45 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 UK key country dynamics
  • Fig. 47 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Germany key country dynamics
  • Fig. 49 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 France key country dynamics
  • Fig. 51 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Italy key country dynamics
  • Fig. 53 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Spain key country dynamics
  • Fig. 55 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark key country dynamics
  • Fig. 57 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Sweden key country dynamics
  • Fig. 59 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Norway key country dynamics
  • Fig. 61 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Asia Pacific
  • Fig. 63 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 China key country dynamics
  • Fig. 65 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Japan key country dynamics
  • Fig. 67 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 India key country dynamics
  • Fig. 69 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Australia key country dynamics
  • Fig. 71 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 South Korea key country dynamics
  • Fig. 73 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Thailand key country dynamics
  • Fig. 75 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Latin America
  • Fig. 77 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Brazil key country dynamics
  • Fig. 79 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Argentina key country dynamics
  • Fig. 81 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Middle East and Africa
  • Fig. 83 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 South Africa key country dynamics
  • Fig. 85 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Saudi Arabia key country dynamics
  • Fig. 87 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 UAE key country dynamics
  • Fig. 89 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Kuwait key country dynamics
  • Fig. 91 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)